Palantir Technologies (PLTR) is preparing to report third-quarter results on Monday, Nov. 2, with Wall Street expecting another revenue beat and a routine guidance raise. Analysts from Oppenheimer and J.P. Morgan have increased their bullish stance, with J.P. Morgan initiating coverage at Overweight and setting a $262 price target for December 2027. The stock currently trades at a forward P/E of 103x, having climbed significantly since June despite rising earnings estimates. Market consensus for 2026 revenue already exceeds the top of Palantir's own guidance range, suggesting that management will need to provide a substantial fourth-quarter guide well above $2.4 billion to meaningfully lift 2027 estimates and justify the high valuation multiple. Key metrics driving investor sentiment include U.S. commercial revenue growth, which surged 149% in the second quarter, and total remaining deal value, which increased 83% to $13.1 billion. While Palantir has a history of beating guidance by large margins, analysts emphasize that future stock performance will depend on whether the company can accelerate growth rates in commercial segments and expand its remaining deal value pipeline faster than revenue. Analysts project normalized EPS of $2.35 for 2027, representing about 50% year-over-year growth. However, the market is pricing in significant expansion, and a mere token raise may fail to move the stock given the high multiple. The upcoming earnings report will be critical for validating whether Palantir can sustain its rapid growth trajectory and deliver on the transformative ROI it claims to provide customers.